Lantmannen Medical AB   Report issue

For profit Phase 2
Founded: Stockholm Sweden (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2019
NCT04116138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Lantmännen | Lantmannen Medical AB